TAK-137
TAK-137_102
Phase 1 small_molecule terminated
Quick answer
TAK-137 for Attention-Deficit/Hyperactivity Disorder is a Phase 1 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Attention-Deficit/Hyperactivity Disorder
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated